Arena Pharmaceuticals to Release Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update on February 23

Rhea-AI Summary

Arena Pharmaceuticals (NASDAQ: ARNA) is set to release its fourth quarter and full-year 2021 financial results on February 23, 2022, after the U.S. market closes. This update will include a corporate overview, relevant developments, and future expectations.

Arena aims to provide crucial medicines to patients, focusing on innovative solutions. They emphasize the urgency in addressing stakeholder needs and executing their strategies effectively.

Positive

• Scheduled financial results release indicates transparency and ongoing corporate communication.

Negative

• None.

PARK CITY, Utah--(BUSINESS WIRE)-- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its fourth quarter and full-year 2021 financial results and provide a corporate update on Wednesday, February 23, 2022, after the close of the U.S. financial markets.

About Arena Pharmaceuticals

ARENA Pharmaceuticals is a team with a singular purpose – deliver important medicines to patients.

In a rapidly changing global market, we work with a sense of urgency every day to understand the needs of all our stakeholders, identify bold, sometimes disruptive, ideas to get medicines to patients, and relentlessly execute until it’s done.

ARENA - Care More. Act Differently.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's corporate update webcast, purpose, work, ideas, and execution. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include those disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220209006010/en/

Corporate Contacts:

Patrick Malloy

Arena Pharmaceuticals, Inc.

Vice President, Investor Relations & Corporate Communications

pmalloy@arenapharm.com

847.987.4878

Source: Arena Pharmaceuticals, Inc.

FAQ

When will Arena Pharmaceuticals release its Q4 2021 financial results?

Arena Pharmaceuticals will release its Q4 2021 financial results on February 23, 2022, after the U.S. market close.

What will Arena Pharmaceuticals include in their corporate update on February 23, 2022?

The corporate update will include fourth quarter and full-year financial results as well as important corporate developments.

What is Arena Pharmaceuticals' stock symbol?

Arena Pharmaceuticals trades under the stock symbol ARNA.